Mutations in the valosin-containing protein (VCP) gene were recently reported to be the cause of 1%-2% of familial amyotrophic lateral sclerosis (ALS) cases. VCP mutations are known to cause inclusion body myopathy (IBM) with Paget's disease (PDB) and frontotemporal dementia (FTD). The presence of VCP mutations in patients with sporadic ALS, sporadic ALS-FTD, and progressive muscular atrophy (PMA), a known clinical mimic of inclusion body myopathy, is not known. To determine the identity and frequency of VCP mutations we screened a cohort of 93 familial ALS, 754 sporadic ALS, 58 sporadic ALS-FTD, and 264 progressive muscular atrophy patients for mutations in the VCP gene. Two nonsynonymous mutations were detected; 1 known mutation (p.R159H) in a patient with familial ALS with several family members suffering from FTD, and 1 mutation (p.I114V) in a patient with sporadic ALS. Conservation analysis and protein prediction software indicate the p.I114V mutation to be a rare benign polymorphism. VCP mutations are a rare cause of familial ALS. The role of VCP mutations in sporadic ALS, if present, appears limited.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2011.10.006DOI Listing

Publication Analysis

Top Keywords

vcp mutations
24
sporadic als
16
familial als
12
vcp
8
amyotrophic lateral
8
lateral sclerosis
8
mutations
8
vcp gene
8
als
8
inclusion body
8

Similar Publications

Loss of function of VCP/TER94 causes neurodegeneration.

Dis Model Mech

December 2024

Department of Biomolecular Science, Faculty of Science, Toho University, Chiba 274-8510, Japan.

Article Synopsis
  • Mutations in certain genes are associated with frontotemporal lobar degeneration (FTLD), but whether these mutations lead to gain or loss of function is still debated.
  • Research using Drosophila flies showed that knocking down the TER94 gene, similar to the human gene VCP/p97, resulted in severe health issues like early death and changes in brain structure, which were not restored by a known mutant version of the gene.
  • The study implies that the issues caused by TER94 knockdown are due to loss-of-function effects, particularly affecting cell proliferation and leading to the loss of another protein, TBPH, from cell nuclei.
View Article and Find Full Text PDF

Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.

Mol Neurodegener

November 2024

Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.

Article Synopsis
  • Microglia, the brain's immune cells, are vital for neuron health but may worsen conditions like ALS and FTD, and their exact role in these diseases is still unclear.
  • Researchers created specialized cultures of microglia from human stem cells with VCP mutations to study their behavior and effects on nearby nerve cells and supportive cells, using advanced techniques like RNA sequencing and proteomics.
  • The studies revealed that VCP mutant microglia show immune system and lysosomal issues, react differently to inflammation compared to healthy microglia, and can influence motor neurons and astrocytes through secreted factors, even though certain genetic factors didn't fully address their dysfunction.
View Article and Find Full Text PDF

The Parkinson's Families Project is a UK-wide study aimed at identifying genetic variation associated with familial and early-onset Parkinson's disease (PD). We recruited individuals with a clinical diagnosis of PD and age at motor symptom onset ≤45 years and/or a family history of PD in up to third-degree relatives. Where possible, we also recruited affected and unaffected relatives.

View Article and Find Full Text PDF
Article Synopsis
  • The SFTPC gene mutation (SFTPCI73T) is a major cause of interstitial lung disease, leading to limited treatment options.
  • Research shows that EMC3 is crucial for maintaining surfactant balance in alveolar type 2 cells and influences the metabolism of the SFTPCI73T mutation.
  • Findings indicate that deleting Emc3 can improve lung structure and function in mice with the SFTPCI73T mutation, revealing new therapeutic targets, particularly involving Valosin Containing Protein (VCP) for treatment.
View Article and Find Full Text PDF

A pathogenic mutation in the ALS/FTD gene VCP induces mitochondrial hypermetabolism by modulating the permeability transition pore.

Acta Neuropathol Commun

October 2024

Laboratory of Neurobiology, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.

Article Synopsis
  • Valosin-containing protein (VCP) is linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), and this study investigates how a mutation in VCP affects mitochondrial function using CRISPR/Cas9 in neuroblastoma cells.
  • The mutated cells show enlarged mitochondria with a depolarized membrane potential, leading to increased respiration and heightened activity in the electron transport chain.
  • The findings suggest that VCP mutations may cause mitochondrial hypermetabolism through changes in the permeability transition pore (mPTP), impacting mitochondrial function and contributing to disease progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!